CEO Punit Dhillon highlighted significant progress with the clinical development of nimacimab, including the completion of patient enrollment for the CBeyond Phase IIa trial ahead of schedule. The ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology provider for modern clinical trials, today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in ...
Hosted on MSN
Co-Diagnostics outlines clinical trial timeline and targets mid-2026 commercialization for PCR platform
CEO Dwight H. Egan reported continued progress on the Co-DX PCR point-of-care platform, stating, "We remain on track to initiate clinical evaluations for all tests in our pipeline during 2025." Egan ...
Egan indicated all four indications—COVID-19, multiplex flu A/B, COVID-19 and RSV test, TB, and HPV—are expected to enter clinical trials during the remainder of 2025. "We anticipate to begin with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback